WASHINGTON, June 2, 2022
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq:
VNDA) today announced that the company will participate in the
Jefferies 2022 Global Healthcare Conference in New York City on Thursday, June 9, 2022. A corporate presentation
is scheduled for 3:30 p.m. Eastern
Time.
The corporate presentation given at the Jefferies 2022 Global
Healthcare Conference may be accessed live on Vanda's corporate
website, www.vandapharma.com. Investors should click on the
Investors tab and follow the link under Recent Events. Investors
are advised to go to the conference website at least 15 minutes
early to register, download, and install any necessary software or
presentations. A link to the archived conference will be available
on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading
global biopharmaceutical company focused on the development and
commercialization of innovative therapies to address high unmet
medical needs and improve the lives of patients. For more on Vanda
Pharmaceuticals Inc., please visit www.vandapharma.com and follow
us on Twitter @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jefferies-2022-global-healthcare-conference-301560548.html
SOURCE Vanda Pharmaceuticals Inc.